- Home
- AKRO vs CIVI Comparison
AKRO vs CIVI Comparison
Compare AKRO & CIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CIVI
- Stock Information
- Founded
- AKRO 2017
- CIVI 1999
- Country
- AKRO United States
- CIVI United States
- Employees
- AKRO N/A
- CIVI N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CIVI Oil & Gas Production
- Sector
- AKRO Health Care
- CIVI Energy
- Exchange
- AKRO Nasdaq
- CIVI Nasdaq
- Market Cap
- AKRO 2.8B
- CIVI 2.6B
- IPO Year
- AKRO 2019
- CIVI 2011
- Fundamental
- Price
- AKRO $39.85
- CIVI $27.63
- Analyst Decision
- AKRO Strong Buy
- CIVI Buy
- Analyst Count
- AKRO 9
- CIVI 12
- Target Price
- AKRO $76.29
- CIVI $61.80
- AVG Volume (30 Days)
- AKRO 1.1M
- CIVI 1.9M
- Earning Date
- AKRO 05-16-2025
- CIVI 05-07-2025
- Dividend Yield
- AKRO N/A
- CIVI 7.23%
- EPS Growth
- AKRO N/A
- CIVI 5.61
- EPS
- AKRO N/A
- CIVI 8.73
- Revenue
- AKRO N/A
- CIVI $5,071,808,000.00
- Revenue This Year
- AKRO N/A
- CIVI N/A
- Revenue Next Year
- AKRO N/A
- CIVI $0.57
- P/E Ratio
- AKRO N/A
- CIVI $3.17
- Revenue Growth
- AKRO N/A
- CIVI 22.15
- 52 Week Low
- AKRO $17.86
- CIVI $22.79
- 52 Week High
- AKRO $58.40
- CIVI $78.63
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- CIVI 43.31
- Support Level
- AKRO $41.60
- CIVI $25.86
- Resistance Level
- AKRO $46.47
- CIVI $28.11
- Average True Range (ATR)
- AKRO 2.26
- CIVI 1.24
- MACD
- AKRO 0.08
- CIVI 0.22
- Stochastic Oscillator
- AKRO 21.84
- CIVI 36.95
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CIVI Civitas Resources Inc.
Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.